<DOC>
	<DOCNO>NCT02433509</DOCNO>
	<brief_summary>The objective study determine safely Human Umbilical Cord Blood mononuclear cell Intravenous injection acute ischemic stroke patient .</brief_summary>
	<brief_title>Phase I Clinical Safety Study About Human Umbilical Cord Blood Monocyte Acute Ischemic Stroke</brief_title>
	<detailed_description>The study use Umbilical Cord Blood cell ( special kind cell believe stem cell ) isolate UCB ( blood obtain birth umbilical cord blood baby ) . StemCyte , lead accredit UCB bank company branch United States Taiwan , provide unit UCB match least 6 6 HLA ( human leukocyte antigen ) transplantation . The HLA-matching use match cell organs transplantation body reject cell . Then cell injection Intravenous acute ischemic stroke patient .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>1 . The age Subjects 45 80 year . 2 . Acute Ischemic Stroke . 3 . National Institutes Health Stroke Scale ( NIHSS ) :818 ( left brain ) 815 ( right brain ) 4 . Brain MRI show middle cerebral artery region ( M1 M2 ) cerebral infarction stroke patient . 5 . Subjects midline shift hemorrhagic transformation 1 . NIHSS score reduce 4 within 12~24 hour . 2 . Female pregnant lactating . 3 . Subjects impair liver function , AIDS , cancer significant medical condition ( include certifiable disease , rare disease ) 4 . Subjects join clinical trail receive rtPA therapy . 5 . Immune dysfunction receive immunosuppressive agent . 6 . Subjects MRI test 7 . Subjects ' HLA type result match less 6 6 genotype</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>acute ischemic stroke</keyword>
	<keyword>umbilical cord blood</keyword>
</DOC>